Kintor Pharma sets Hong Kong IPO in motion

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Kintor Pharma sets Hong Kong IPO in motion

Jonathan Breen
May 12, 2020 06:45 AM
pills adobe stock 575x375 pharmaceuticals

China-based Kintor Pharmaceutical has kicked off bookbuilding for its Hong Kong listing, the latest in a stream of healthcare IPOs in the city. The issuer is targeting HK$1.86bn ($240.1m) in proceeds.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechUBSEquityChina Merchants Bank CoChinaChina International Capital CorpHong Kong SARAsiaCoronavirusGreater ChinaHaitong SecuritiesNortheast AsiaAsia PacificEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article